Duke University Health System’s Post

Excited to announce that our quality improvement initiative focused on enhancing advance care planning for lymphoma and myeloma patients treated with CAR T-cell therapy has received an ASCO Conquer Cancer Merit Award! 🎉 By incorporating structured reminders into our workflow and using an Epic SmartBlock, we significantly increased advance care planning rates, ensuring that patient preferences for care are properly recorded prior to CAR T-cell therapy. An expansion study in patients treated with bispecific T-cell engagers is planned, with broader rollout within our entire hematologic malignancy group in the future. Abstract: https://lnkd.in/g3vXmgkJ Authors: Charles Gaulin , Frances Cervoni-Curet , Anath Lionel, Misha Hawkins, MSN, RN, OCN , Sairah Ahmed , Melody Becnel , Maria Alma Rodriguez MD Anderson Cancer Center #ASCO #ConquerCancer #CART #Celltherapy #Lymphoma #Myeloma #AdvanceCarePlanning #PatientCenteredCare #ASCOQTLY24

Covering #cancer services during war, the workforce crisis, the need for quality care for all patients, pragmatic #ClinicalTrials, cancer #prevention, early detection, screening and more. The European Cancer Summit report presents the landscape of #CancerCare and current challenges.

ICYMI: In this episode of OncLive On Air, Ryan Merkow, MD, MS, of the University of Chicago Medicine Comprehensive Cancer Center, and Louise Catherine Connell, MB BCh BAO, BMedSc, of Memorial Sloan Kettering Cancer Center, discuss the use of HAI therapy for patients with colorectal cancer. https://lnkd.in/eZsDpEin

Attending #aacr2024? Stop by and visit my poster, Abstract 5494: Spatial organization between claudin and the tumor microenvironment in head and neck squamous cell carcinomas Presentation: April 9, 2024, 1:30 p.m. – 5:00 p.m. | Section 10 | Poster Board #16 We'll be highlighting utility of our own end to end spatial solution, MultiOmyx together with #nanostring IO360 gene expression for a comprehensive analysis of the TME of squamous cell carcinomas.

Key highlights you should know from this year's World Conference on Lung Cancer 👉 https://bit.ly/wclc2024 Earlier this month, the Outcomes4Me team was at the #WCLC24 in San Diego. Explore some of the emerging research in lung cancer that we learned from this global conference. #NSCLC #NCCNLung #DigitalHealth #PatientAdvocacy

MATCHMAKERS, one of three #CancerGrandChallenges teams co-funded by The Mark Foundation for Cancer Research, is taking on our T-cell receptors challenge. We recently spoke with Michael Birnbaum (MIT Koch Institute for Integrative Cancer Research, team lead of MATCHMAKERS) and Ryan Schoenfeld (CEO, The Mark Foundation for Cancer Research) about the team's ambitious approach to the challenge. Read the article 👉 https://bit.ly/3zr1iPi

Esophageal Cancer is in the spotlight for the 2nd issue of the April Newsletter at Cancer Consultants Of America. Follow the link to view the latest issue: https://lnkd.in/eBZ4vRva

Unveiling the most powerful currency in the world - The Cancer Currency! Crafted by VML HEALTH and EUROPA DONNA - The European Breast Cancer Coalition, it symbolizes the inherent value of those living with metastatic breast cancer. Join the movement that secures recognition and funding within Europe’s Beating Cancer Plan. More in Ad Age here: https://bit.ly/3SSBQZO

CU Cancer Center members Breelyn Wilky, MD, and Steven Thorpe, MD, FACS, share what someone with sarcoma can expect coming to the CU Cancer Center. To learn more about sarcoma, see our webpage here: https://lnkd.in/gkifv33a #SarcomaCancerAwarenessMonth #SarcomaAwareness

Culturally tailored, community based approaches are an effective tool for improving colorectal cancer screening in populations underutilizing cancer prevention strategies.